You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
拱東醫療(605369.SH)2020年淨利增長98.86%至2.26億元 擬10轉4派18元
格隆匯 03-07 14:54

格隆匯 3 月 7日丨拱東醫療(605369.SH)發佈2020年年度報吿,2020年公司實現營業收入82,965.18萬元,較上年同期增長50.03%;實現歸屬於上市公司股東的淨利潤22,588.10萬元,較上年同期增長98.86%;實現扣除非經常性損益後的歸屬於母公司所有者淨利潤21,504.38萬元,較上年同期增長95.28%。基本每股收益3.48元。公司擬向全體股東每10股派發現金紅利18.00元(含税),擬向全體股東以資本公積金轉增股本方式每10股轉增4股。

公司主營業務為一次性醫用耗材的研發、生產和銷售,主要產品可分為真空採血系統、實驗檢測類耗材、體液採集類耗材、醫用護理類耗材和藥品包裝材料等類型,產品廣泛應用於臨牀診斷和護理、科研檢測、藥品包裝等領域。

公司作為高新技術企業,一貫重視產品的研發和技術創新,不斷提升生產技術和工藝水平,並建立了完善的質量控制體系。公司已通過ISO13485質量管理體系認證,“實驗室及醫用耗材”被浙江省質量技術監督局認定為浙江名牌產品,多個產品通過歐盟CE認證,一次性使用無菌陰道擴張器及鋭器收集桶產品獲得美國FDA510(k)許可。憑藉高質量的產品和優質的服務,公司獲得了境內、外客户的認可,產品覆蓋了境內絕大部分省市,並銷往北美洲、亞洲、南美洲、非洲、歐洲的多個國家和地區。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account